Kenmerk
Fatigue
A subjective feeling of tiredness characterized by a lack of energy and motivation.
Samenvatting
- Ook bekend als
- Tired, Tiredness
- Lichaamssysteem
- Constitutional symptom
ReferentiegenoomGRCh38hg38
Posities op gen- en variantpagina's volgen deze keuze, in deze browser.
Read the genes linked to Fatigue, and the rest of your genome, with one test.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken
Mijn Genome Test bestellen501 genen gekoppeld aan Fatigue
Veranderingen in deze genen veroorzaken zeldzame aandoeningen waarbij Fatigue voorkomt. De meeste mensen met dit kenmerk hebben geen van die aandoeningen, en een gen op deze lijst zegt niets over het eigen genoom van iemand.
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| ABCC9ATP binding cassette subfamily C member 9 | Altijd | In 3 aandoeningen |
| ALBalbumin | Altijd | In 2 aandoeningen |
| CST3cystatin C | Altijd | In 1 aandoening |
| EMDemerin | Altijd | In 1 aandoening |
| FDXRferredoxin reductase | Altijd | In 1 aandoening |
| FLT3LGfms related receptor tyrosine kinase 3 ligand | Altijd | In 1 aandoening |
| GAAalpha glucosidase | Altijd | In 1 aandoening |
| GFAPglial fibrillary acidic protein | Altijd | In 1 aandoening |
| GYS1glycogen synthase 1 | Altijd | In 1 aandoening |
| HEPHL1hephaestin like 1 | Altijd | In 1 aandoening |
| IL18BPinterleukin 18 binding protein | Altijd | In 1 aandoening |
| IL21interleukin 21 | Altijd | In 1 aandoening |
| ITPR3inositol 1,4,5-trisphosphate receptor type 3 | Altijd | In 1 aandoening |
| JPH1junctophilin 1 | Altijd | In 1 aandoening |
| KLklotho | Altijd | In 1 aandoening |
| KLF1KLF transcription factor 1 | Altijd | In 1 aandoening |
| LMNAlamin A/C | Altijd | In 2 aandoeningen |
| LRIF1ligand dependent nuclear receptor interacting factor 1 | Altijd | In 1 aandoening |
| LYNLYN proto-oncogene, Src family tyrosine kinase | Altijd | In 1 aandoening |
| MAU2MAU2 sister chromatid cohesion factor | Altijd | In 1 aandoening |
| NDC1NDC1 transmembrane nucleoporin | Altijd | In 1 aandoening |
| NEXNnexilin F-actin binding protein | Altijd | In 2 aandoeningen |
| NLRC4NLR family CARD domain containing 4 | Altijd | In 1 aandoening |
| NOTCH3notch receptor 3 | Altijd | In 1 aandoening |
| NRAPnebulin related anchoring protein | Altijd | In 2 aandoeningen |
| PIGTphosphatidylinositol glycan anchor biosynthesis class T | Altijd | In 1 aandoening |
| PIK3CGphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | Altijd | In 1 aandoening |
| PLEKHM1pleckstrin homology and RUN domain containing M1 | Altijd | In 1 aandoening |
| PNPLA8patatin like domain 8, phospholipase A2 | Altijd | In 1 aandoening |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Altijd | In 2 aandoeningen |
| PTCRApre T cell antigen receptor alpha | Altijd | In 1 aandoening |
| PTPMT1protein tyrosine phosphatase mitochondrial 1 | Altijd | In 1 aandoening |
| RIN2Ras and Rab interactor 2 | Altijd | In 1 aandoening |
| SCN4Asodium voltage-gated channel alpha subunit 4 | Altijd | In 2 aandoeningen |
| SLC18A2solute carrier family 18 member A2 | Altijd | In 2 aandoeningen |
| SLC25A4solute carrier family 25 member 4 | Altijd | In 2 aandoeningen |
| TAFAZZINtafazzin, phospholipid-lysophospholipid transacylase | Altijd | In 2 aandoeningen |
| THRBthyroid hormone receptor beta | Altijd | In 1 aandoening |
| ZMYM3zinc finger MYM-type containing 3 | Altijd | In 1 aandoening |
| AIPAHR interacting HSP90 co-chaperone | Heel vaak (80–99%) | In 2 aandoeningen |
Toon nog 461 genen
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| ALAS25'-aminolevulinate synthase 2 | Heel vaak (80–99%) | In 1 aandoening |
| ATMATM serine/threonine kinase | Heel vaak (80–99%) | In 2 aandoeningen |
| ATP7AATPase copper transporting alpha | Heel vaak (80–99%) | In 1 aandoening |
| ATRXATRX chromatin remodeler | Heel vaak (80–99%) | In 1 aandoening |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Heel vaak (80–99%) | In 1 aandoening |
| BCL10BCL10 immune signaling adaptor | Heel vaak (80–99%) | In 1 aandoening |
| BIRC3baculoviral IAP repeat containing 3 | Heel vaak (80–99%) | In 1 aandoening |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Heel vaak (80–99%) | In 1 aandoening |
| BLNKB cell linker | Heel vaak (80–99%) | In 1 aandoening |
| BMPR1Abone morphogenetic protein receptor type 1A | Heel vaak (80–99%) | In 1 aandoening |
| BRCA2BRCA2 DNA repair associated | Heel vaak (80–99%) | In 2 aandoeningen |
| BTKBruton tyrosine kinase | Heel vaak (80–99%) | In 1 aandoening |
| C4Acomplement C4A (Chido/Rodgers blood group) | Heel vaak (80–99%) | In 2 aandoeningen |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Heel vaak (80–99%) | In 1 aandoening |
| CALRcalreticulin | Heel vaak (80–99%) | In 2 aandoeningen |
| CCR1C-C motif chemokine receptor 1 | Heel vaak (80–99%) | In 1 aandoening |
| CD4CD4 molecule | Heel vaak (80–99%) | In 1 aandoening |
| CD79ACD79a molecule | Heel vaak (80–99%) | In 1 aandoening |
| CD79BCD79b molecule | Heel vaak (80–99%) | In 1 aandoening |
| CHEK2checkpoint kinase 2 | Heel vaak (80–99%) | In 1 aandoening |
| CPT1Acarnitine palmitoyltransferase 1A | Heel vaak (80–99%) | In 1 aandoening |
| CR2complement C3d receptor 2 | Heel vaak (80–99%) | In 1 aandoening |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Heel vaak (80–99%) | In 2 aandoeningen |
| DDB2damage specific DNA binding protein 2 | Heel vaak (80–99%) | In 1 aandoening |
| DNASE1deoxyribonuclease 1 | Heel vaak (80–99%) | In 1 aandoening |
| EPCAMepithelial cell adhesion molecule | Heel vaak (80–99%) | In 1 aandoening |
| EPORerythropoietin receptor | Heel vaak (80–99%) | In 2 aandoeningen |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Heel vaak (80–99%) | In 1 aandoening |
| ERCC2ERCC excision repair 2, TFIIH core complex helicase subunit | Heel vaak (80–99%) | In 1 aandoening |
| ERCC3ERCC excision repair 3, TFIIH core complex helicase subunit | Heel vaak (80–99%) | In 1 aandoening |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Heel vaak (80–99%) | In 1 aandoening |
| ERCC5ERCC excision repair 5, endonuclease | Heel vaak (80–99%) | In 1 aandoening |
| ETS1ETS proto-oncogene 1, transcription factor | Heel vaak (80–99%) | In 1 aandoening |
| FASFas cell surface death receptor | Heel vaak (80–99%) | In 1 aandoening |
| FCGR2BFc gamma receptor IIb | Heel vaak (80–99%) | In 1 aandoening |
| FCGR3BFc gamma receptor IIIb | Heel vaak (80–99%) | In 1 aandoening |
| FOXE1forkhead box E1 | Heel vaak (80–99%) | In 1 aandoening |
| FOXP1forkhead box P1 | Heel vaak (80–99%) | In 1 aandoening |
| GATA2GATA binding protein 2 | Heel vaak (80–99%) | In 1 aandoening |
| GBA1glucosylceramidase beta 1 | Heel vaak (80–99%) | In 1 aandoening |
| GLAgalactosidase alpha | Heel vaak (80–99%) | In 1 aandoening |
| GPR101G protein-coupled receptor 101 | Heel vaak (80–99%) | In 1 aandoening |
| HBA1hemoglobin subunit alpha 1 | Heel vaak (80–99%) | In 1 aandoening |
| HBA2hemoglobin subunit alpha 2 | Heel vaak (80–99%) | In 1 aandoening |
| HLA-Bmajor histocompatibility complex, class I, B | Heel vaak (80–99%) | In 4 aandoeningen |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Heel vaak (80–99%) | In 1 aandoening |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Heel vaak (80–99%) | In 2 aandoeningen |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Heel vaak (80–99%) | In 5 aandoeningen |
| HNF4Ahepatocyte nuclear factor 4 alpha | Heel vaak (80–99%) | In 1 aandoening |
| IFNGR1interferon gamma receptor 1 | Heel vaak (80–99%) | In 1 aandoening |
| IGHimmunoglobulin heavy locus | Heel vaak (80–99%) | In 3 aandoeningen |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Heel vaak (80–99%) | In 1 aandoening |
| IGHMimmunoglobulin heavy constant mu | Heel vaak (80–99%) | In 1 aandoening |
| IGLL1immunoglobulin lambda like polypeptide 1 | Heel vaak (80–99%) | In 1 aandoening |
| IKZF1IKAROS family zinc finger 1 | Heel vaak (80–99%) | In 1 aandoening |
| IL10interleukin 10 | Heel vaak (80–99%) | In 3 aandoeningen |
| IL12Ainterleukin 12A | Heel vaak (80–99%) | In 2 aandoeningen |
| IL12A-AS1IL12A antisense RNA 1 | Heel vaak (80–99%) | In 1 aandoening |
| IL12Binterleukin 12B | Heel vaak (80–99%) | In 1 aandoening |
| IL23Rinterleukin 23 receptor | Heel vaak (80–99%) | In 1 aandoening |
| IRAK1interleukin 1 receptor associated kinase 1 | Heel vaak (80–99%) | In 1 aandoening |
| IRF4interferon regulatory factor 4 | Heel vaak (80–99%) | In 1 aandoening |
| IRF5interferon regulatory factor 5 | Heel vaak (80–99%) | In 2 aandoeningen |
| ITGAMintegrin subunit alpha M | Heel vaak (80–99%) | In 1 aandoening |
| JAK2Janus kinase 2 | Heel vaak (80–99%) | In 4 aandoeningen |
| JAZF1JAZF zinc finger 1 | Heel vaak (80–99%) | In 1 aandoening |
| KIAA0319LKIAA0319 like | Heel vaak (80–99%) | In 1 aandoening |
| KLRC4killer cell lectin like receptor C4 | Heel vaak (80–99%) | In 1 aandoening |
| KRASKRas proto-oncogene, GTPase | Heel vaak (80–99%) | In 1 aandoening |
| LBRlamin B receptor | Heel vaak (80–99%) | In 1 aandoening |
| LRRC8Aleucine rich repeat containing 8 VRAC subunit A | Heel vaak (80–99%) | In 1 aandoening |
| MALT1MALT1 paracaspase | Heel vaak (80–99%) | In 1 aandoening |
| MECP2methyl-CpG binding protein 2 | Heel vaak (80–99%) | In 1 aandoening |
| MEFVMEFV innate immunity regulator, pyrin | Heel vaak (80–99%) | In 2 aandoeningen |
| MLH1mutL homolog 1 | Heel vaak (80–99%) | In 1 aandoening |
| MLXMAX dimerization protein MLX | Heel vaak (80–99%) | In 1 aandoening |
| MMADHCmetabolism of cobalamin associated D | Heel vaak (80–99%) | In 1 aandoening |
| MPLMPL proto-oncogene, thrombopoietin receptor | Heel vaak (80–99%) | In 2 aandoeningen |
| MSH2mutS homolog 2 | Heel vaak (80–99%) | In 1 aandoening |
| MSH6mutS homolog 6 | Heel vaak (80–99%) | In 1 aandoening |
| MUTYHmutY DNA glycosylase | Heel vaak (80–99%) | In 1 aandoening |
| MYH7myosin heavy chain 7 | Heel vaak (80–99%) | In 2 aandoeningen |
| NFKB2nuclear factor kappa B subunit 2 | Heel vaak (80–99%) | In 1 aandoening |
| NKX2-1NK2 homeobox 1 | Heel vaak (80–99%) | In 1 aandoening |
| NKX2-5NK2 homeobox 5 | Heel vaak (80–99%) | In 4 aandoeningen |
| NLRP3NLR family pyrin domain containing 3 | Heel vaak (80–99%) | In 3 aandoeningen |
| NPATnuclear protein, coactivator of histone transcription | Heel vaak (80–99%) | In 1 aandoening |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Heel vaak (80–99%) | In 2 aandoeningen |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Heel vaak (80–99%) | In 1 aandoening |
| PABPN1poly(A) binding protein nuclear 1 | Heel vaak (80–99%) | In 1 aandoening |
| PAX8paired box 8 | Heel vaak (80–99%) | In 3 aandoeningen |
| PDCD1programmed cell death 1 | Heel vaak (80–99%) | In 1 aandoening |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Heel vaak (80–99%) | In 1 aandoening |
| PIK3CDphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | Heel vaak (80–99%) | In 1 aandoening |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Heel vaak (80–99%) | In 1 aandoening |
| PMS1PMS1 homolog 1, mismatch repair system component | Heel vaak (80–99%) | In 1 aandoening |
| PMS2PMS1 homolog 2, mismatch repair system component | Heel vaak (80–99%) | In 1 aandoening |
| POLD1DNA polymerase delta 1, catalytic subunit | Heel vaak (80–99%) | In 1 aandoening |
| POLEDNA polymerase epsilon, catalytic subunit | Heel vaak (80–99%) | In 1 aandoening |
| PRTN3proteinase 3 | Heel vaak (80–99%) | In 1 aandoening |
| PSTPIP1proline-serine-threonine phosphatase interacting protein 1 | Heel vaak (80–99%) | In 1 aandoening |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Heel vaak (80–99%) | In 3 aandoeningen |
| PXKPX domain containing serine/threonine kinase like | Heel vaak (80–99%) | In 1 aandoening |
| RPS20ribosomal protein S20 | Heel vaak (80–99%) | In 1 aandoening |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Heel vaak (80–99%) | In 5 aandoeningen |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Heel vaak (80–99%) | In 4 aandoeningen |
| SDHCsuccinate dehydrogenase complex subunit C | Heel vaak (80–99%) | In 3 aandoeningen |
| SEMA4Asemaphorin 4A | Heel vaak (80–99%) | In 1 aandoening |
| SH2B3SH2B adaptor protein 3 | Heel vaak (80–99%) | In 2 aandoeningen |
| SLC26A4solute carrier family 26 member 4 | Heel vaak (80–99%) | In 2 aandoeningen |
| SPI1Spi-1 proto-oncogene | Heel vaak (80–99%) | In 1 aandoening |
| SPP1secreted phosphoprotein 1 | Heel vaak (80–99%) | In 1 aandoening |
| STAT4signal transducer and activator of transcription 4 | Heel vaak (80–99%) | In 2 aandoeningen |
| TBX19T-box transcription factor 19 | Heel vaak (80–99%) | In 1 aandoening |
| TCF3transcription factor 3 | Heel vaak (80–99%) | In 1 aandoening |
| TET2tet methylcytosine dioxygenase 2 | Heel vaak (80–99%) | In 5 aandoeningen |
| TGFBR2transforming growth factor beta receptor 2 | Heel vaak (80–99%) | In 1 aandoening |
| TLR4toll like receptor 4 | Heel vaak (80–99%) | In 1 aandoening |
| TLR7toll like receptor 7 | Heel vaak (80–99%) | In 1 aandoening |
| TNFAIP3TNF alpha induced protein 3 | Heel vaak (80–99%) | In 1 aandoening |
| TNFSF4TNF superfamily member 4 | Heel vaak (80–99%) | In 1 aandoening |
| TNIP1TNFAIP3 interacting protein 1 | Heel vaak (80–99%) | In 1 aandoening |
| TP53tumor protein p53 | Heel vaak (80–99%) | In 1 aandoening |
| TREX1three prime repair exonuclease 1 | Heel vaak (80–99%) | In 1 aandoening |
| TSHRthyroid stimulating hormone receptor | Heel vaak (80–99%) | In 2 aandoeningen |
| UBAC2UBA domain containing 2 | Heel vaak (80–99%) | In 1 aandoening |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Heel vaak (80–99%) | In 1 aandoening |
| XPAXPA, DNA damage recognition and repair factor | Heel vaak (80–99%) | In 1 aandoening |
| XPCXPC complex subunit, DNA damage recognition and repair factor | Heel vaak (80–99%) | In 1 aandoening |
| ABCA3ATP binding cassette subfamily A member 3 | Vaak (30–79%) | In 1 aandoening |
| ABCD1ATP binding cassette subfamily D member 1 | Vaak (30–79%) | In 1 aandoening |
| ABL1ABL proto-oncogene 1, non-receptor tyrosine kinase | Vaak (30–79%) | In 1 aandoening |
| ACTA1actin alpha 1, skeletal muscle | Vaak (30–79%) | In 1 aandoening |
| ACTC1actin alpha cardiac muscle 1 | Vaak (30–79%) | In 2 aandoeningen |
| ACTN2actinin alpha 2 | Vaak (30–79%) | In 1 aandoening |
| ADGRV1adhesion G protein-coupled receptor V1 | Vaak (30–79%) | In 1 aandoening |
| ALKALK receptor tyrosine kinase | Vaak (30–79%) | In 1 aandoening |
| ANGangiogenin | Vaak (30–79%) | In 1 aandoening |
| ANKRD1ankyrin repeat domain 1 | Vaak (30–79%) | In 1 aandoening |
| ANXA11annexin A11 | Vaak (30–79%) | In 1 aandoening |
| AP1S3adaptor related protein complex 1 subunit sigma 3 | Vaak (30–79%) | In 1 aandoening |
| ASXL1ASXL transcriptional regulator 1 | Vaak (30–79%) | In 2 aandoeningen |
| ATP11AATPase phospholipid transporting 11A | Vaak (30–79%) | In 1 aandoening |
| ATP13A2ATPase cation transporting 13A2 | Vaak (30–79%) | In 3 aandoeningen |
| ATXN2ataxin 2 | Vaak (30–79%) | In 1 aandoening |
| BAG3BAG cochaperone 3 | Vaak (30–79%) | In 1 aandoening |
| BAG5BAG cochaperone 5 | Vaak (30–79%) | In 1 aandoening |
| BCL2BCL2 apoptosis regulator | Vaak (30–79%) | In 1 aandoening |
| BCL6BCL6 transcription repressor | Vaak (30–79%) | In 1 aandoening |
| BCORBCL6 corepressor | Vaak (30–79%) | In 1 aandoening |
| BCRBCR activator of RhoGEF and GTPase | Vaak (30–79%) | In 1 aandoening |
| BMP6bone morphogenetic protein 6 | Vaak (30–79%) | In 1 aandoening |
| BRCA1BRCA1 DNA repair associated | Vaak (30–79%) | In 1 aandoening |
| BTNL2butyrophilin like 2 | Vaak (30–79%) | In 1 aandoening |
| CAP2cyclase associated actin cytoskeleton regulatory protein 2 | Vaak (30–79%) | In 1 aandoening |
| CARMIL2capping protein regulator and myosin 1 linker 2 | Vaak (30–79%) | In 1 aandoening |
| CBLCbl proto-oncogene | Vaak (30–79%) | In 1 aandoening |
| CCND1cyclin D1 | Vaak (30–79%) | In 2 aandoeningen |
| CCNFcyclin F | Vaak (30–79%) | In 1 aandoening |
| CD46CD46 molecule | Vaak (30–79%) | In 1 aandoening |
| CDC73cell division cycle 73 | Vaak (30–79%) | In 2 aandoeningen |
| CDH23cadherin related 23 | Vaak (30–79%) | In 2 aandoeningen |
| CFAP410cilia and flagella associated protein 410 | Vaak (30–79%) | In 1 aandoening |
| CFHcomplement factor H | Vaak (30–79%) | In 1 aandoening |
| CFIcomplement factor I | Vaak (30–79%) | In 1 aandoening |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Vaak (30–79%) | In 1 aandoening |
| CHMP2Bcharged multivesicular body protein 2B | Vaak (30–79%) | In 1 aandoening |
| CITED2Cbp/p300 interacting transactivator with ED-rich tail 2 | Vaak (30–79%) | In 2 aandoeningen |
| CLCN7Cl-/H+ antiporter 7 | Vaak (30–79%) | In 1 aandoening |
| COL1A1collagen type I alpha 1 chain | Vaak (30–79%) | In 1 aandoening |
| COL5A1collagen type V alpha 1 chain | Vaak (30–79%) | In 1 aandoening |
| COL5A2collagen type V alpha 2 chain | Vaak (30–79%) | In 1 aandoening |
| COL9A2collagen type IX alpha 2 chain | Vaak (30–79%) | In 1 aandoening |
| CRYABcrystallin alpha B | Vaak (30–79%) | In 1 aandoening |
| CSRP3cysteine and glycine rich protein 3 | Vaak (30–79%) | In 1 aandoening |
| CTNNB1catenin beta 1 | Vaak (30–79%) | In 1 aandoening |
| DAOD-amino acid oxidase | Vaak (30–79%) | In 1 aandoening |
| DBHdopamine beta-hydroxylase | Vaak (30–79%) | In 1 aandoening |
| DCTN1dynactin subunit 1 | Vaak (30–79%) | In 1 aandoening |
| DESdesmin | Vaak (30–79%) | In 1 aandoening |
| DLSTdihydrolipoamide S-succinyltransferase | Vaak (30–79%) | In 1 aandoening |
| DMDdystrophin | Vaak (30–79%) | In 2 aandoeningen |
| DNAJC6DnaJ heat shock protein family (Hsp40) member C6 | Vaak (30–79%) | In 1 aandoening |
| DNMT3ADNA methyltransferase 3 alpha | Vaak (30–79%) | In 1 aandoening |
| DOLKdolichol kinase | Vaak (30–79%) | In 1 aandoening |
| DPP9dipeptidyl peptidase 9 | Vaak (30–79%) | In 1 aandoening |
| DSG2desmoglein 2 | Vaak (30–79%) | In 1 aandoening |
| DSPdesmoplakin | Vaak (30–79%) | In 2 aandoeningen |
| ELANEelastase, neutrophil expressed | Vaak (30–79%) | In 1 aandoening |
| EPAS1endothelial PAS domain protein 1 | Vaak (30–79%) | In 1 aandoening |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Vaak (30–79%) | In 1 aandoening |
| FAM13Afamily with sequence similarity 13 member A | Vaak (30–79%) | In 1 aandoening |
| FGF23fibroblast growth factor 23 | Vaak (30–79%) | In 1 aandoening |
| FHfumarate hydratase | Vaak (30–79%) | In 1 aandoening |
| FHL2four and a half LIM domains 2 | Vaak (30–79%) | In 1 aandoening |
| FIG4FIG4 phosphoinositide 5-phosphatase | Vaak (30–79%) | In 1 aandoening |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Vaak (30–79%) | In 1 aandoening |
| FKTNfukutin | Vaak (30–79%) | In 1 aandoening |
| FLNCfilamin C | Vaak (30–79%) | In 1 aandoening |
| FOXA2forkhead box A2 | Vaak (30–79%) | In 1 aandoening |
| FUSFUS RNA binding protein | Vaak (30–79%) | In 1 aandoening |
| GATA4GATA binding protein 4 | Vaak (30–79%) | In 2 aandoeningen |
| GATA5GATA binding protein 5 | Vaak (30–79%) | In 1 aandoening |
| GATA6GATA binding protein 6 | Vaak (30–79%) | In 2 aandoeningen |
| GATAD1GATA zinc finger domain containing 1 | Vaak (30–79%) | In 1 aandoening |
| GCH1GTP cyclohydrolase 1 | Vaak (30–79%) | In 1 aandoening |
| GCKglucokinase | Vaak (30–79%) | In 1 aandoening |
| GET3guided entry of tail-anchored proteins factor 3, ATPase | Vaak (30–79%) | In 1 aandoening |
| GJA5gap junction protein alpha 5 | Vaak (30–79%) | In 1 aandoening |
| GLE1GLE1 RNA export mediator | Vaak (30–79%) | In 1 aandoening |
| GLI2GLI family zinc finger 2 | Vaak (30–79%) | In 1 aandoening |
| GLT8D1glycosyltransferase 8 domain containing 1 | Vaak (30–79%) | In 1 aandoening |
| HACD13-hydroxyacyl-CoA dehydratase 1 | Vaak (30–79%) | In 1 aandoening |
| HACE1HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Vaak (30–79%) | In 1 aandoening |
| HAND2heart and neural crest derivatives expressed 2 | Vaak (30–79%) | In 1 aandoening |
| HAVCR2hepatitis A virus cellular receptor 2 | Vaak (30–79%) | In 1 aandoening |
| HELLPARHELLP associated long non-coding RNA | Vaak (30–79%) | In 1 aandoening |
| HESX1HESX homeobox 1 | Vaak (30–79%) | In 3 aandoeningen |
| HFEhomeostatic iron regulator | Vaak (30–79%) | In 1 aandoening |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Vaak (30–79%) | In 1 aandoening |
| IL36RNinterleukin 36 receptor antagonist | Vaak (30–79%) | In 1 aandoening |
| IMPDH2inosine monophosphate dehydrogenase 2 | Vaak (30–79%) | In 1 aandoening |
| INSRinsulin receptor | Vaak (30–79%) | In 1 aandoening |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Vaak (30–79%) | In 1 aandoening |
| ITGA7integrin subunit alpha 7 | Vaak (30–79%) | In 1 aandoening |
| JPH2junctophilin 2 | Vaak (30–79%) | In 1 aandoening |
| KCNA5potassium voltage-gated channel subfamily A member 5 | Vaak (30–79%) | In 1 aandoening |
| KCNE1potassium voltage-gated channel subfamily E regulatory subunit 1 | Vaak (30–79%) | In 1 aandoening |
| KCNE2potassium voltage-gated channel subfamily E regulatory subunit 2 | Vaak (30–79%) | In 1 aandoening |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Vaak (30–79%) | In 1 aandoening |
| KCNJ3potassium inwardly rectifying channel subfamily J member 3 | Vaak (30–79%) | In 1 aandoening |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Vaak (30–79%) | In 1 aandoening |
| KCNQ1potassium voltage-gated channel subfamily Q member 1 | Vaak (30–79%) | In 1 aandoening |
| KIF1Bkinesin family member 1B | Vaak (30–79%) | In 1 aandoening |
| KIF23kinesin family member 23 | Vaak (30–79%) | In 1 aandoening |
| KITKIT proto-oncogene, receptor tyrosine kinase | Vaak (30–79%) | In 2 aandoeningen |
| LAMA4laminin subunit alpha 4 | Vaak (30–79%) | In 1 aandoening |
| LDB3LIM domain binding 3 | Vaak (30–79%) | In 1 aandoening |
| LHX3LIM homeobox 3 | Vaak (30–79%) | In 1 aandoening |
| LHX4LIM homeobox 4 | Vaak (30–79%) | In 2 aandoeningen |
| LIN28Blin-28 RNA binding posttranscriptional regulator B | Vaak (30–79%) | In 1 aandoening |
| LMO1LIM domain only 1 | Vaak (30–79%) | In 1 aandoening |
| LMOD2leiomodin 2 | Vaak (30–79%) | In 1 aandoening |
| LRP12LDL receptor related protein 12 | Vaak (30–79%) | In 1 aandoening |
| MAP3K20mitogen-activated protein kinase kinase kinase 20 | Vaak (30–79%) | In 1 aandoening |
| MATR3matrin 3 | Vaak (30–79%) | In 1 aandoening |
| MAXMYC associated transcriptional regulator X | Vaak (30–79%) | In 1 aandoening |
| MDH2malate dehydrogenase 2 | Vaak (30–79%) | In 1 aandoening |
| MEN1menin 1 | Vaak (30–79%) | In 2 aandoeningen |
| METMET proto-oncogene, receptor tyrosine kinase | Vaak (30–79%) | In 1 aandoening |
| MORC2MORC family CW-type zinc finger 2 | Vaak (30–79%) | In 1 aandoening |
| MUC5Bmucin 5B, oligomeric mucus/gel-forming | Vaak (30–79%) | In 1 aandoening |
| MYBPC3myosin binding protein C3 | Vaak (30–79%) | In 1 aandoening |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Vaak (30–79%) | In 1 aandoening |
| MYH6myosin heavy chain 6 | Vaak (30–79%) | In 2 aandoeningen |
| MYL2myosin light chain 2 | Vaak (30–79%) | In 1 aandoening |
| MYL4myosin light chain 4 | Vaak (30–79%) | In 1 aandoening |
| MYO7Amyosin VIIA | Vaak (30–79%) | In 1 aandoening |
| MYPNmyopalladin | Vaak (30–79%) | In 1 aandoening |
| MYT1Lmyelin transcription factor 1 like | Vaak (30–79%) | In 1 aandoening |
| NAA80N-alpha-acetyltransferase 80, NatH catalytic subunit | Vaak (30–79%) | In 1 aandoening |
| NABP1nucleic acid binding protein 1 | Vaak (30–79%) | In 1 aandoening |
| NEFHneurofilament heavy chain | Vaak (30–79%) | In 1 aandoening |
| NEK1NIMA related kinase 1 | Vaak (30–79%) | In 1 aandoening |
| NF1neurofibromin 1 | Vaak (30–79%) | In 1 aandoening |
| NIT1nitrilase 1 | Vaak (30–79%) | In 1 aandoening |
| NKX2-6NK2 homeobox 6 | Vaak (30–79%) | In 1 aandoening |
| NPM1nucleophosmin 1 | Vaak (30–79%) | In 1 aandoening |
| NPPAnatriuretic peptide A | Vaak (30–79%) | In 2 aandoeningen |
| NR0B1nuclear receptor subfamily 0 group B member 1 | Vaak (30–79%) | In 1 aandoening |
| NR4A2nuclear receptor subfamily 4 group A member 2 | Vaak (30–79%) | In 1 aandoening |
| NUMA1nuclear mitotic apparatus protein 1 | Vaak (30–79%) | In 1 aandoening |
| NUP155nucleoporin 155 | Vaak (30–79%) | In 1 aandoening |
| OPA1OPA1 mitochondrial dynamin like GTPase | Vaak (30–79%) | In 2 aandoeningen |
| OPTNoptineurin | Vaak (30–79%) | In 1 aandoening |
| OTX2orthodenticle homeobox 2 | Vaak (30–79%) | In 2 aandoeningen |
| PARNpoly(A)-specific ribonuclease | Vaak (30–79%) | In 1 aandoening |
| PDGFRAplatelet derived growth factor receptor alpha | Vaak (30–79%) | In 1 aandoening |
| PDZD7PDZ domain containing 7 | Vaak (30–79%) | In 1 aandoening |
| PFN1profilin 1 | Vaak (30–79%) | In 1 aandoening |
| PHIPPHIP subunit of CUL4-Ring ligase complex | Vaak (30–79%) | In 1 aandoening |
| PHKA1phosphorylase kinase regulatory subunit alpha 1 | Vaak (30–79%) | In 1 aandoening |
| PHKG1phosphorylase kinase catalytic subunit gamma 1 | Vaak (30–79%) | In 1 aandoening |
| PHOX2Bpaired like homeobox 2B | Vaak (30–79%) | In 1 aandoening |
| PITX2paired like homeodomain 2 | Vaak (30–79%) | In 1 aandoening |
| PLNphospholamban | Vaak (30–79%) | In 1 aandoening |
| PMLPML nuclear body scaffold | Vaak (30–79%) | In 1 aandoening |
| PODXLpodocalyxin like | Vaak (30–79%) | In 1 aandoening |
| POLGDNA polymerase gamma, catalytic subunit | Vaak (30–79%) | In 1 aandoening |
| POLG2DNA polymerase gamma 2, accessory subunit | Vaak (30–79%) | In 1 aandoening |
| POLR3GLRNA polymerase III subunit GL | Vaak (30–79%) | In 1 aandoening |
| POU1F1POU class 1 homeobox 1 | Vaak (30–79%) | In 2 aandoeningen |
| PPCSphosphopantothenoylcysteine synthetase | Vaak (30–79%) | In 1 aandoening |
| PRDM16PR/SET domain 16 | Vaak (30–79%) | In 1 aandoening |
| PREPLprolyl endopeptidase like | Vaak (30–79%) | In 1 aandoening |
| PROP1PROP paired-like homeobox 1 | Vaak (30–79%) | In 3 aandoeningen |
| PRPHperipherin | Vaak (30–79%) | In 1 aandoening |
| PSEN1presenilin 1 | Vaak (30–79%) | In 1 aandoening |
| PSEN2presenilin 2 | Vaak (30–79%) | In 1 aandoening |
| PTPN3protein tyrosine phosphatase non-receptor type 3 | Vaak (30–79%) | In 1 aandoening |
| RACGAP1Rac GTPase activating protein 1 | Vaak (30–79%) | In 1 aandoening |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Vaak (30–79%) | In 1 aandoening |
| RAPSNreceptor associated protein of the synapse | Vaak (30–79%) | In 1 aandoening |
| RARAretinoic acid receptor alpha | Vaak (30–79%) | In 1 aandoening |
| RBM20RNA binding motif protein 20 | Vaak (30–79%) | In 1 aandoening |
| RETret proto-oncogene | Vaak (30–79%) | In 2 aandoeningen |
| ROS1ROS proto-oncogene 1, receptor tyrosine kinase | Vaak (30–79%) | In 1 aandoening |
| RPL3Lribosomal protein L3 like | Vaak (30–79%) | In 1 aandoening |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Vaak (30–79%) | In 2 aandoeningen |
| RTEL1regulator of telomere elongation helicase 1 | Vaak (30–79%) | In 1 aandoening |
| RUNX1RUNX family transcription factor 1 | Vaak (30–79%) | In 2 aandoeningen |
| RYR1ryanodine receptor 1 | Vaak (30–79%) | In 1 aandoening |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Vaak (30–79%) | In 1 aandoening |
| SCN2Bsodium voltage-gated channel beta subunit 2 | Vaak (30–79%) | In 1 aandoening |
| SCN3Bsodium voltage-gated channel beta subunit 3 | Vaak (30–79%) | In 1 aandoening |
| SCN4Bsodium voltage-gated channel beta subunit 4 | Vaak (30–79%) | In 1 aandoening |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Vaak (30–79%) | In 3 aandoeningen |
| SCNN1Asodium channel epithelial 1 subunit alpha | Vaak (30–79%) | In 1 aandoening |
| SCNN1Bsodium channel epithelial 1 subunit beta | Vaak (30–79%) | In 1 aandoening |
| SCNN1Gsodium channel epithelial 1 subunit gamma | Vaak (30–79%) | In 1 aandoening |
| SDHAF2succinate dehydrogenase complex assembly factor 2 | Vaak (30–79%) | In 1 aandoening |
| SDHDsuccinate dehydrogenase complex subunit D | Vaak (30–79%) | In 2 aandoeningen |
| SELENONselenoprotein N | Vaak (30–79%) | In 1 aandoening |
| SFTPA1surfactant protein A1 | Vaak (30–79%) | In 1 aandoening |
| SFTPA2surfactant protein A2 | Vaak (30–79%) | In 1 aandoening |
| SFTPCsurfactant protein C | Vaak (30–79%) | In 1 aandoening |
| SGCDsarcoglycan delta | Vaak (30–79%) | In 1 aandoening |
| SLC25A11solute carrier family 25 member 11 | Vaak (30–79%) | In 1 aandoening |
| SLC2A10solute carrier family 2 member 10 | Vaak (30–79%) | In 1 aandoening |
| SLC34A2solute carrier family 34 member 2 | Vaak (30–79%) | In 1 aandoening |
| SLC3A1solute carrier family 3 member 1 | Vaak (30–79%) | In 1 aandoening |
| SLC4A1solute carrier family 4 member 1 (Diego blood group) | Vaak (30–79%) | In 1 aandoening |
| SOD1superoxide dismutase 1 | Vaak (30–79%) | In 1 aandoening |
| SOX17SRY-box transcription factor 17 | Vaak (30–79%) | In 1 aandoening |
| SOX3SRY-box transcription factor 3 | Vaak (30–79%) | In 2 aandoeningen |
| SQSTM1sequestosome 1 | Vaak (30–79%) | In 1 aandoening |
| SRSF2serine and arginine rich splicing factor 2 | Vaak (30–79%) | In 2 aandoeningen |
| STAT3signal transducer and activator of transcription 3 | Vaak (30–79%) | In 1 aandoening |
| STAT5Bsignal transducer and activator of transcription 5B | Vaak (30–79%) | In 1 aandoening |
| STEAP3STEAP3 metalloreductase | Vaak (30–79%) | In 1 aandoening |
| STN1STN1 subunit of CST complex | Vaak (30–79%) | In 1 aandoening |
| SYNJ1synaptojanin 1 | Vaak (30–79%) | In 2 aandoeningen |
| TAF15TATA-box binding protein associated factor 15 | Vaak (30–79%) | In 1 aandoening |
| TAF1ATATA-box binding protein associated factor, RNA polymerase I subunit A | Vaak (30–79%) | In 1 aandoening |
| TARDBPTAR DNA binding protein | Vaak (30–79%) | In 1 aandoening |
| TBK1TANK binding kinase 1 | Vaak (30–79%) | In 2 aandoeningen |
| TBL1XR1TBL1X/Y related 1 | Vaak (30–79%) | In 1 aandoening |
| TBX20T-box transcription factor 20 | Vaak (30–79%) | In 1 aandoening |
| TCAPtitin-cap | Vaak (30–79%) | In 1 aandoening |
| TERCtelomerase RNA component | Vaak (30–79%) | In 1 aandoening |
| TERTtelomerase reverse transcriptase | Vaak (30–79%) | In 1 aandoening |
| TICAM1TIR domain containing adaptor molecule 1 | Vaak (30–79%) | In 1 aandoening |
| TLL1tolloid like 1 | Vaak (30–79%) | In 2 aandoeningen |
| TLR3toll like receptor 3 | Vaak (30–79%) | In 1 aandoening |
| TMEM126Btransmembrane protein 126B | Vaak (30–79%) | In 1 aandoening |
| TMEM127transmembrane protein 127 | Vaak (30–79%) | In 1 aandoening |
| TMPOthymopoietin | Vaak (30–79%) | In 1 aandoening |
| TNNC1troponin C1, slow skeletal and cardiac type | Vaak (30–79%) | In 1 aandoening |
| TNNI3troponin I3, cardiac type | Vaak (30–79%) | In 1 aandoening |
| TNNT2troponin T2, cardiac type | Vaak (30–79%) | In 1 aandoening |
| TNXBtenascin XB | Vaak (30–79%) | In 1 aandoening |
| TPM1tropomyosin 1 | Vaak (30–79%) | In 1 aandoening |
| TPM2tropomyosin 2 | Vaak (30–79%) | In 2 aandoeningen |
| TPM3tropomyosin 3 | Vaak (30–79%) | In 1 aandoening |
| TRAF3TNF receptor associated factor 3 | Vaak (30–79%) | In 1 aandoening |
| TREM2triggering receptor expressed on myeloid cells 2 | Vaak (30–79%) | In 1 aandoening |
| TRHRthyrotropin releasing hormone receptor | Vaak (30–79%) | In 2 aandoeningen |
| TRIOtrio Rho guanine nucleotide exchange factor | Vaak (30–79%) | In 1 aandoening |
| TSHBthyroid stimulating hormone subunit beta | Vaak (30–79%) | In 1 aandoening |
| TTNtitin | Vaak (30–79%) | In 2 aandoeningen |
| TWNKtwinkle mtDNA helicase | Vaak (30–79%) | In 2 aandoeningen |
| TXNRD2thioredoxin reductase 2 | Vaak (30–79%) | In 1 aandoening |
| UBQLN2ubiquilin 2 | Vaak (30–79%) | In 1 aandoening |
| UNC13Aunc-13 homolog A | Vaak (30–79%) | In 1 aandoening |
| UNC93B1unc-93B1 regulator of TLR signaling | Vaak (30–79%) | In 1 aandoening |
| USH2Ausherin | Vaak (30–79%) | In 1 aandoening |
| VAPBVAMP associated protein B and C | Vaak (30–79%) | In 2 aandoeningen |
| VCLvinculin | Vaak (30–79%) | In 1 aandoening |
| VCPvalosin containing protein | Vaak (30–79%) | In 1 aandoening |
| VEZF1vascular endothelial zinc finger 1 | Vaak (30–79%) | In 1 aandoening |
| VHLvon Hippel-Lindau tumor suppressor | Vaak (30–79%) | In 3 aandoeningen |
| WASWASP actin nucleation promoting factor | Vaak (30–79%) | In 1 aandoening |
| WHRNwhirlin | Vaak (30–79%) | In 1 aandoening |
| ZBTB16zinc finger and BTB domain containing 16 | Vaak (30–79%) | In 1 aandoening |
| ABCC2ATP binding cassette subfamily C member 2 | Soms (5–29%) | In 1 aandoening |
| ACADMacyl-CoA dehydrogenase medium chain | Soms (5–29%) | In 1 aandoening |
| ADAMTS2ADAM metallopeptidase with thrombospondin type 1 motif 2 | Soms (5–29%) | In 1 aandoening |
| ADAMTSL2ADAMTS like 2 | Soms (5–29%) | In 1 aandoening |
| AP2S1adaptor related protein complex 2 subunit sigma 1 | Soms (5–29%) | In 1 aandoening |
| ARNT2aryl hydrocarbon receptor nuclear translocator 2 | Soms (5–29%) | In 1 aandoening |
| ASCC3activating signal cointegrator 1 complex subunit 3 | Soms (5–29%) | In 1 aandoening |
| C1QBPcomplement C1q binding protein | Soms (5–29%) | In 1 aandoening |
| CNBPCCHC-type zinc finger nucleic acid binding protein | Soms (5–29%) | In 1 aandoening |
| COL1A2collagen type I alpha 2 chain | Soms (5–29%) | In 1 aandoening |
| EPB41erythrocyte membrane protein band 4.1 | Soms (5–29%) | In 1 aandoening |
| FGFR1fibroblast growth factor receptor 1 | Soms (5–29%) | In 1 aandoening |
| FTLferritin light chain | Soms (5–29%) | In 1 aandoening |
| GIMAP5GTPase, IMAP family member 5 | Soms (5–29%) | In 1 aandoening |
| GPR35G protein-coupled receptor 35 | Soms (5–29%) | In 1 aandoening |
| GRM1glutamate metabotropic receptor 1 | Soms (5–29%) | In 1 aandoening |
| GYPCglycophorin C (Gerbich blood group) | Soms (5–29%) | In 1 aandoening |
| HMGCL3-hydroxy-3-methylglutaryl-CoA lyase | Soms (5–29%) | In 1 aandoening |
| IGHG2immunoglobulin heavy constant gamma 2 (G2m marker) | Soms (5–29%) | In 1 aandoening |
| IGKCimmunoglobulin kappa constant | Soms (5–29%) | In 1 aandoening |
| IL12RB1interleukin 12 receptor subunit beta 1 | Soms (5–29%) | In 1 aandoening |
| KPNA3karyopherin subunit alpha 3 | Soms (5–29%) | In 1 aandoening |
| MMEL1membrane metalloendopeptidase like 1 | Soms (5–29%) | In 1 aandoening |
| MST1macrophage stimulating 1 | Soms (5–29%) | In 1 aandoening |
| MT-TKmitochondrially encoded tRNA-Lys (AAA/G) | Soms (5–29%) | In 1 aandoening |
| MYD88MYD88 innate immune signal transduction adaptor | Soms (5–29%) | In 1 aandoening |
| NAB2NGFI-A binding protein 2 | Soms (5–29%) | In 1 aandoening |
| NAGSN-acetylglutamate synthase | Soms (5–29%) | In 1 aandoening |
| NAXENAD(P)HX epimerase | Soms (5–29%) | In 1 aandoening |
| PGM1phosphoglucomutase 1 | Soms (5–29%) | In 1 aandoening |
| PHEXphosphate regulating endopeptidase X-linked | Soms (5–29%) | In 1 aandoening |
| PHKA2phosphorylase kinase regulatory subunit alpha 2 | Soms (5–29%) | In 2 aandoeningen |
| PHKBphosphorylase kinase regulatory subunit beta | Soms (5–29%) | In 1 aandoening |
| PHKG2phosphorylase kinase catalytic subunit gamma 2 | Soms (5–29%) | In 1 aandoening |
| PLECplectin | Soms (5–29%) | In 1 aandoening |
| POU2AF1POU class 2 homeobox associating factor 1 | Soms (5–29%) | In 1 aandoening |
| PPP2R5Dprotein phosphatase 2 regulatory subunit B'delta | Soms (5–29%) | In 1 aandoening |
| PROKR2prokineticin receptor 2 | Soms (5–29%) | In 1 aandoening |
| PYGMglycogen phosphorylase, muscle associated | Soms (5–29%) | In 1 aandoening |
| RHAGRh associated glycoprotein | Soms (5–29%) | In 1 aandoening |
| SEMA4Dsemaphorin 4D | Soms (5–29%) | In 1 aandoening |
| SIsucrase-isomaltase | Soms (5–29%) | In 1 aandoening |
| SIN3ASIN3 transcription regulator family member A | Soms (5–29%) | In 1 aandoening |
| SLC40A1solute carrier family 40 member 1 | Soms (5–29%) | In 1 aandoening |
| SOX2SRY-box transcription factor 2 | Soms (5–29%) | In 1 aandoening |
| SPIBSpi-B transcription factor | Soms (5–29%) | In 1 aandoening |
| SPTA1spectrin alpha, erythrocytic 1 | Soms (5–29%) | In 1 aandoening |
| SPTBspectrin beta, erythrocytic | Soms (5–29%) | In 1 aandoening |
| STAT1signal transducer and activator of transcription 1 | Soms (5–29%) | In 1 aandoening |
| STAT6signal transducer and activator of transcription 6 | Soms (5–29%) | In 1 aandoening |
| TCF4transcription factor 4 | Soms (5–29%) | In 1 aandoening |
| TNFSF15TNF superfamily member 15 | Soms (5–29%) | In 1 aandoening |
| TNPO3transportin 3 | Soms (5–29%) | In 1 aandoening |
| TSC1TSC complex subunit 1 | Soms (5–29%) | In 1 aandoening |
| TSC2TSC complex subunit 2 | Soms (5–29%) | In 1 aandoening |
| UNC45Bunc-45 myosin chaperone B | Soms (5–29%) | In 1 aandoening |
| YY1YY1 transcription factor | Soms (5–29%) | In 1 aandoening |
| DNM1Ldynamin 1L | Zelden (1–4%) | In 1 aandoening |
| PPIBpeptidylprolyl isomerase B | Zelden (1–4%) | In 1 aandoening |
| SPTBN1spectrin beta, non-erythrocytic 1 | Zelden (1–4%) | In 1 aandoening |
| AGKacylglycerol kinase | Niet vastgelegd | In 1 aandoening |
| APTXaprataxin | Niet vastgelegd | In 1 aandoening |
| ARMC5armadillo repeat containing 5 | Niet vastgelegd | In 1 aandoening |
| CAV3caveolin 3 | Niet vastgelegd | In 1 aandoening |
| CD244CD244 molecule | Niet vastgelegd | In 1 aandoening |
| CIITAclass II major histocompatibility complex transactivator | Niet vastgelegd | In 1 aandoening |
| COQ2coenzyme Q2, polyprenyltransferase | Niet vastgelegd | In 1 aandoening |
| DYSFdysferlin | Niet vastgelegd | In 1 aandoening |
| NFKBIL1NFKB inhibitor like 1 | Niet vastgelegd | In 1 aandoening |
| POMGNT1protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) | Niet vastgelegd | In 1 aandoening |
| SERPINA6serpin family A member 6 | Niet vastgelegd | In 1 aandoening |
| SLC12A3solute carrier family 12 member 3 | Niet vastgelegd | In 1 aandoening |
| SLC18A3solute carrier family 18 member A3 | Niet vastgelegd | In 1 aandoening |
| SLC22A4solute carrier family 22 member 4 | Niet vastgelegd | In 1 aandoening |
| SLC25A26solute carrier family 25 member 26 | Niet vastgelegd | In 1 aandoening |
| TFR2transferrin receptor 2 | Niet vastgelegd | In 1 aandoening |
| UBA1ubiquitin like modifier activating enzyme 1 | Niet vastgelegd | In 1 aandoening |
Hoe vaak dit voorkomt bij mensen met een van de aandoeningen van het gen, de hoogste frequentie binnen die aandoeningen, zoals de Human Phenotype Ontology dit vastlegt. Deze pagina's beschrijven kenmerken en het onderzoek erachter; het zijn geen diagnose, en over symptomen kunt u het best een arts of genetisch adviseur raadplegen.
Smallere kenmerken
Bredere kenmerken
Waar dit vandaan komt
- De Human Phenotype Ontology, release 2026-09-01: het kenmerk, de namen, de definitie en de genen die ermee verbonden zijn. Meer informatie vindt u op hpo.jax.org.
- Gegevensrelease 2026.10.16-c6eea6bf.
Eén test. Een leven lang antwoorden.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken